Kairos Pharma Investor Relations Material
Latest events
Q1 2025
13 May, 2025
Q4 2024
14 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Kairos Pharma Ltd
Access all reports
Kairos Pharma Ltd is a biopharmaceutical company focused on the development of cancer therapies. The company is engaged in researching and advancing novel treatments targeting various types of cancer through immunotherapy, targeted therapy, and combination approaches. The company is headquartered in Los Angeles, California, and its shares are listed on the OTC markets.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
KAPA
Country
🇺🇸 United States